TRAMONTANO, ENZO
 Distribuzione geografica
Continente #
EU - Europa 417.389
NA - Nord America 18.466
AS - Asia 9.113
SA - Sud America 1.447
AF - Africa 300
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 14
Totale 446.753
Nazione #
IT - Italia 412.565
US - Stati Uniti d'America 18.173
SG - Singapore 3.584
CN - Cina 3.004
SE - Svezia 1.178
BR - Brasile 1.097
UA - Ucraina 968
VN - Vietnam 892
DE - Germania 614
FI - Finlandia 570
GB - Regno Unito 467
FR - Francia 426
HK - Hong Kong 329
IN - India 236
KR - Corea 172
CA - Canada 154
AR - Argentina 139
NL - Olanda 117
BD - Bangladesh 114
TR - Turchia 100
MX - Messico 97
IQ - Iraq 95
JP - Giappone 93
MA - Marocco 93
AT - Austria 79
PL - Polonia 75
RU - Federazione Russa 71
ZA - Sudafrica 70
PK - Pakistan 67
EC - Ecuador 59
ID - Indonesia 57
ES - Italia 48
CO - Colombia 39
SA - Arabia Saudita 39
IR - Iran 37
BE - Belgio 36
PH - Filippine 33
VE - Venezuela 33
UZ - Uzbekistan 31
IE - Irlanda 26
TN - Tunisia 25
IL - Israele 23
AE - Emirati Arabi Uniti 22
CZ - Repubblica Ceca 21
KE - Kenya 21
AU - Australia 20
CL - Cile 20
AZ - Azerbaigian 19
EG - Egitto 19
JO - Giordania 19
PY - Paraguay 18
MY - Malesia 17
NP - Nepal 16
TW - Taiwan 16
PT - Portogallo 15
BO - Bolivia 14
DZ - Algeria 14
ET - Etiopia 14
LT - Lituania 13
UY - Uruguay 13
DK - Danimarca 12
EU - Europa 11
GE - Georgia 11
KG - Kirghizistan 11
OM - Oman 11
PE - Perù 11
CH - Svizzera 10
GR - Grecia 10
LB - Libano 9
NO - Norvegia 9
KZ - Kazakistan 8
LV - Lettonia 8
QA - Qatar 8
RO - Romania 8
HU - Ungheria 7
PA - Panama 7
TH - Thailandia 7
JM - Giamaica 6
MU - Mauritius 6
NG - Nigeria 6
SK - Slovacchia (Repubblica Slovacca) 6
AL - Albania 5
BG - Bulgaria 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
HR - Croazia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
CI - Costa d'Avorio 4
HN - Honduras 4
KH - Cambogia 4
MN - Mongolia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BW - Botswana 3
BY - Bielorussia 3
SN - Senegal 3
Totale 446.696
Città #
Cagliari 401.167
Uta 9.931
Singapore 1.960
Ashburn 1.852
Fairfield 1.590
Woodbridge 1.319
San Jose 1.116
Dallas 1.003
Chandler 993
Houston 824
Boardman 778
Nyköping 727
Seattle 660
Wilmington 645
Ann Arbor 561
Beijing 552
Cambridge 550
Jacksonville 471
Los Angeles 392
Helsinki 373
Dearborn 349
New York 347
Council Bluffs 288
Hong Kong 277
Santa Clara 266
Lauterbourg 245
Ho Chi Minh City 235
Shanghai 232
Hefei 222
The Dalles 212
Boston 194
Nanjing 186
Hanoi 174
Dong Ket 170
Seoul 151
Buffalo 136
Milan 109
San Diego 107
São Paulo 102
Rome 99
Chicago 93
Munich 91
Redwood City 88
Guangzhou 79
Tokyo 73
Herndon 71
Nanchang 68
Redondo Beach 63
London 62
Orem 61
Toronto 60
Changsha 59
Phoenix 58
Warsaw 58
Casablanca 57
Tianjin 56
Frankfurt am Main 55
Amsterdam 54
Atlanta 53
Mountain View 53
Shenyang 53
Vienna 52
Hangzhou 48
Jiaxing 43
Rio de Janeiro 42
Sassari 42
Washington 41
Nuremberg 40
Verona 40
Hebei 38
Lappeenranta 38
Brooklyn 36
Da Nang 35
Baghdad 34
Mexico City 34
Wuhan 34
Redmond 33
Chennai 32
Montreal 32
San Francisco 32
Stockholm 32
Istanbul 31
Denver 30
Mumbai 29
Salt Lake City 29
Norwalk 28
Tashkent 28
Jinan 26
Guayaquil 25
Manchester 25
Brasília 24
Brussels 24
Curitiba 24
Haiphong 24
Zhengzhou 24
Dublin 23
Poplar 23
Johannesburg 22
Birmingham 21
Lahore 21
Totale 434.169
Nome #
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series 20.820
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.721
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.681
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.523
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.467
Biological activities of aerial parts extracts of Euphorbia characias 4.439
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.329
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.184
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.746
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.514
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.483
Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions 3.457
Dual HIV-1 reverse transcriptase and integrase inhibitors from Limonium morisianum Arrigoni, an endemic species of Sardinia (Italy) 3.443
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.432
Onopordum illyricum L.: new anti HIV-1 agents from a Mediterranean edible plant 3.412
Broad-range potential of Asphodelus microcarpus leaves extract for drug development 3.367
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.337
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.309
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.306
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.295
Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein 3.275
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.102
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.086
Inhibition of HIV-1 reverse transcriptase dimerization by small molecules 3.075
Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication 3.049
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition 3.044
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.035
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 3.000
Insights into Ebola Virus VP35 and VP24 Interferon inhibitory functions and their initial exploitation as drug targets 2.989
Purification and characterization of DR_2577 (SlpA) a major S-layer protein from Deinococcus radiodurans 2.961
Preliminary study of endemic plants of Sardinia as a source of new antiviral agents 2.928
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.920
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.911
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 2.892
Structure-guided approach identifies a novel class of HIV-1 Ribonuclease H inhibitors: Binding mode insights through magnesium complexation and site-directed mutagenesis studies 2.885
Chelation motifs affecting metal-dependent viral enzymes: N′-acylhydrazone ligands as dual target inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H domain 2.878
Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities 2.873
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.861
On the S-layer of Thermus thermophilus and the assembling of its main protein SIpA 2.845
The S-layer protein DR_2577 binds deinoxanthin and under desiccation conditions protects against UV-radiation in Deinococcus radiodurans 2.841
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding 2.830
Insights into Ebola VP35 oligomerization from molecular simulations 2.816
Development and validation of a novel dual luciferase reporter gene assay to quantify Ebola virus VP24 inhibition of IFN signaling 2.785
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.770
Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity 2.766
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.730
null 2.719
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H 2.708
ANALYSIS OF 98 HERV-K(HML-2) CONTAINING PROVIRUSES IDENTIFIED IN THE HUMAN GENOME ASSEMBLY GRCH37/HG19 BY RETROTECTOR AND THEIR GENOMIC CONTEXT 2.701
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase 2.634
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.631
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.612
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.608
Identification of a novel HERV-K(HML10): comprehensive characterization and comparative analysis in non-human primates provide insights about HML10 proviruses structure and diffusion 2.571
Use of a Dual Luciferase Cell-Based Drug Screening Assay to Study VP24 Inhibition of JAK/STAT Pathway and its Reversion by Compounds 2.566
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.545
Classification and characterization of human endogenous retroviruses; mosaic forms are common 2.543
Contribution of type W human endogenous retroviruses to the human genome: Characterization of HERV-W proviral insertions and processed pseudogenes 2.483
Human Endogenous Retrovirus type W distribution in the human genome: identification and characterization of a new set of proviral sequences in GRCh37/hg19 assembly 2.476
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.457
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.447
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.434
Integration of SARS-CoV-2 RNA in infected human cells by retrotransposons: an unlikely hypothesis and old viral relationships 2.433
Structure-Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain 2.422
Inhibition of HIV-1 reverse transcriptase associated activities by the hydroalcoholic extract of Casimiroa edulis seeds 2.419
Validation of a computed radiography device to monitor the HIV-1 RNase H activity 2.405
An efficient route to novel uracil-based drug-like molecules 2.368
Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities 2.354
Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops 2.343
null 2.329
Identification and genomic characterization of HERV-K (HML-10) in human genome GRCh37/hg19 assembly 2.316
A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35–Associated Inhibition of Double-Stranded RNA–Stimulated, Retinoic Acid–Inducible Gene 1–Mediated Induction of Interferon β 2.306
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.261
2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication 2.257
HERV-W group evolutionary history in non-human primates: Characterization of ERV-W orthologs in Catarrhini and related ERV groups in Platyrrhini 2.252
1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity 2.228
Development and identification of a novel anti-HIV-1 peptide derived by modification of the N-terminal domain of HIV-1 integrase 2.222
Investigation on the sucrose binding pocket of HIV-1 Integrase by molecular dynamics and synergy experiments 2.217
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.149
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.140
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors 2.130
Human endogenous retroviruses are ancient acquired elements still shaping innate immune responses 2.116
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants 2.109
Meeting report: Third Summer School on innovative approaches for identification of antiviral agents (IAAASS) 2.107
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases 2.103
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 2.075
Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: molecular modeling and biological evaluation 2.075
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.070
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus 2.064
New features of the cell wall of the radio-resistant bacterium Deinococcus radiodurans 2.056
Ebola virus VP35 blocks stress granule assembly 2.042
HERV envelope proteins: Physiological role and pathogenic potential in cancer and autoimmunity 2.038
6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach 2.036
Type W Human Endogenous Retrovirus (HERV-W) Integrations and Their Mobilization by L1 Machinery: Contribution to the Human Transcriptome and Impact on the Host Physiopathology 2.013
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.968
Comprehensive Characterization of the Human Endogenous Retrovirus HERV-K(HML-6) Group: Overview of Structure, Phylogeny, and Contribution to the Human Genome 1.961
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.922
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.881
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 1.880
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase 1.873
Totale 302.487
Categoria #
all - tutte 548.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 548.506


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218.926 0 0 0 0 0 0 0 0 0 0 6.403 2.523
2021/202223.462 2.379 1.875 1.195 1.419 1.852 1.786 1.324 1.202 2.274 2.345 2.865 2.946
2022/202340.300 3.440 5.633 4.589 3.519 2.514 4.377 1.973 3.178 2.117 2.391 3.242 3.327
2023/202438.637 2.373 1.373 2.010 3.476 3.722 6.385 5.038 3.012 1.887 2.286 3.411 3.664
2024/202591.439 15.305 41.501 10.614 7.743 3.619 4.266 5.061 362 795 596 716 861
2025/202618.936 1.402 681 2.392 1.934 1.762 1.440 3.572 1.903 1.418 2.387 45 0
Totale 447.728